1 year return (CAGR)
-19.28%
Cartesian Therapeutics Inc. Exchange (NASDAQ, USD)
RNAC
7.86
-0.15 (-1.83%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-38.28%
5 year return (CAGR)
-43.07%
10 year return (CAGR)
-31.65%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
243.25M
Price/Sales
164.69
Ent value
539.50M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-27.18%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 8.19 |
| Daily high | 8.19 |
| Daily low | 7.96 |
| Daily Volume | 110K |
| All-time high | 789.90 |
| 1y analyst estimate | 34.57 |
| Beta | 0.62 |
| EPS (TTM) | -5.16 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RNAC | S&P500 | |
| Current price drop from All-time high | -99.00% | -1.96% |
| Highest price drop | -99.26% | -56.47% |
| Date of highest drop | 5 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -80.93% | -10.68% |
| Avg time to new high | 129 days | 12 days |
| Max time to new high | 2462 days | 1805 days |
News
